Mirum's Heavy Dependence on Livmarli for Revenues Remains a Woe

Zacks Mar 21 12:20 ET

Morgan Stanley Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $65

Moomoo NewsMar 21 07:31 ET · Ratings

Mirum Pharmaceuticals: Promising Growth Trajectory With Strategic Focus and Pipeline Progress

TipRanksMar 21 06:27 ET

Trade Alert: COO & President Of Mirum Pharmaceuticals Peter Radovich Has Sold Stock

Simply Wall StMar 8 07:37 ET

Director's Bold Move: Major Stock Purchase in Mirum Pharmaceuticals!

TipRanksMar 6 21:20 ET

Insider Sale: PRESIDENT AND COO of $MIRM Sells 1,169 Shares

Quiver QuantitativeMar 5 16:33 ET